Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance

Oncogene
N J TurtonTimothy W Gant

Abstract

The multidrug resistance (MDR) phenotype is a major cause of cancer treatment failure. Here the expressions of 4224 genes were analysed for association with intrinsic or acquired doxorubicin (DOX) resistance. A cluster of overexpressed genes related to DOX resistance was observed. Included in this cluster was ABCB1 the P-glycoprotein transporter protein gene and MMP1 (Matrix Metalloproteinase 1), indicative of the invasive nature of resistant cells, and the oxytocin receptor (OXTR), a potential new therapeutic target. Overexpression of genes associated with xenobiotic transformation, cell transformation, cell signalling and lymphocyte activation was also associated with DOX resistance as was estrogen receptor negativity. In all carcinoma cells, compared with HBL100 a putatively normal breast epithelial cell line, a cluster of overexpressed genes was identified which included several keratins, in particular keratins 8 and 18 which are regulated through the ras signalling pathway. Analysis of genomic amplifications and deletions revealed specific genetic alterations common to both intrinsic and acquired DOX resistance including ABCB1, PGY3 (ABCB4) and BAK. The findings shown here indicate new possibilities for the diagnosis of DO...Continue Reading

References

Jul 1, 1986·Somatic Cell and Molecular Genetics·A FojoI Pastan
Jun 1, 1986·British Journal of Urology·G D WebsterC Zakrzewski
Jul 1, 1983·Analytical Biochemistry·A P Feinberg, B Vogelstein
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Jan 1, 1995·Progress in Growth Factor Research·E TonnerD Flint
Dec 1, 1996·Cancer Metastasis Reviews·R G OshimaC Caulín
Jul 17, 1997·International Journal of Cancer. Journal International Du Cancer·P CassoniG Bussolati
Aug 1, 1998·Journal of Molecular Endocrinology·R StephenP D Darbre
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Jun 1, 1999·Methods in Enzymology·M B Eisen, P O Brown
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·C M PerouD Botstein
Sep 25, 1999·Journal of Cellular Physiology·D R BlatchfordC J Wilde
Sep 30, 1999·International Journal of Cancer. Journal International Du Cancer·A M BambergerK Milde-Langosch
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·J KluckenG Schmitz
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 22, 2001·Endocrine-related Cancer·P E LønningA L Børresen-Dale

❮ Previous
Next ❯

Citations

Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Jason A Bush, Gang Li
Jun 23, 2009·Cancer Chemotherapy and Pharmacology·Ozlem Darcansoy IşeriUfuk Gündüz
Nov 17, 2001·Current Opinion in Pharmacology·J Robert
Feb 6, 2004·Breast Cancer Research and Treatment·Marc Lacroix, Guy Leclercq
May 8, 2004·Nature Reviews. Genetics·Markus Bredel, Edgar Jacoby
May 19, 2006·Pharmacogenetics and Genomics·Guy LeschzinerMichael R Johnson
Apr 7, 2009·Journal of Biological Rhythms·Elizabeth S MaywoodAkhilesh B Reddy
Aug 19, 2007·Expert Opinion on Drug Metabolism & Toxicology·Timothy W Gant
Jun 1, 2004·International Journal of Hematology·Yoshikazu IchikawaKen-ichi Sawada
May 8, 2014·BioMed Research International·Radosław JanuchowskiMaciej Zabel
Feb 1, 2004·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Myung-Ju AhnYong-Sung Lee
Aug 4, 2005·Chronobiology International·Rachel Ben-ShlomoCharalambos P Kyriacou
Mar 7, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Radosław JanuchowskiMaciej Zabel
Dec 1, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Katie RiddTimothy W Gant
Feb 8, 2007·Cancer Genetics and Cytogenetics·Nami YabukiKunio Kitada
Oct 12, 2005·International Journal of Cancer. Journal International Du Cancer·Balazs GyörffyHermann Lage
Apr 9, 2005·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Andrew R GreenIan N H White
Dec 21, 2002·International Journal of Cancer. Journal International Du Cancer·François BertucciDaniel Birnbaum
Apr 17, 2015·Endocrine-related Cancer·Wei Wei, Michael T Lewis
Dec 18, 2013·Biochemical and Biophysical Research Communications·David MonaghanHoward O Fearnhead
Jun 14, 2017·The Pharmacogenomics Journal·D M GattiG A Churchill
Jul 31, 2008·British Journal of Cancer·S Raguz, E Yagüe
Dec 19, 2009·Toxicologic Pathology·Robert D Cardiff, Alexander D Borowsky
Sep 18, 2018·Journal of Drug Targeting·Snigdha Tiash, Ezharul Hoque Chowdhury

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.